BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21545466)

  • 1. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
    John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
    Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
    John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
    Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation.
    Thacker D; Patel A; Dodds K; Goldberg DJ; Semeao E; Rychik J
    Ann Thorac Surg; 2010 Mar; 89(3):837-42. PubMed ID: 20172140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of iron deficiency in protein-losing enteropathy following the Fontan procedure.
    Yetman AT; Everitt MD
    Congenit Heart Dis; 2011; 6(4):370-3. PubMed ID: 21392262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.
    Kelly AM; Feldt RH; Driscoll DJ; Danielson GK
    Mayo Clin Proc; 1998 Aug; 73(8):777-9. PubMed ID: 9703306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation.
    Turner Z; Lanford L; Webber S
    Congenit Heart Dis; 2012; 7(1):24-30. PubMed ID: 22129195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone.
    Grattan MJ; McCrindle BW
    Congenit Heart Dis; 2010; 5(2):165-7. PubMed ID: 20412490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment.
    Meadows J; Jenkins K
    Cardiol Young; 2011 Aug; 21(4):363-77. PubMed ID: 21349233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of long-acting octreotide for protracted gastrointestinal bleeding related to protein-losing enteropathy after the Fontan procedure: a case report.
    Kogawa K; Ando T; Fujiwara M
    Cardiol Young; 2021 Aug; 31(8):1333-1335. PubMed ID: 33588957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-losing enteropathy after the modified fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement.
    Zellers TM; Brown K
    Pediatr Cardiol; 1996; 17(2):115-7. PubMed ID: 8833498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation.
    Kim SJ; Park IS; Song JY; Lee JY; Shim WS
    Ann Thorac Surg; 2004 Apr; 77(4):1456-7. PubMed ID: 15063295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-losing enteropathy and the Fontan operation.
    Johnson JN; Driscoll DJ; O'Leary PW
    Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal bleeding and protein-losing enteropathy after the fontan operation.
    Vyas H; Driscoll DJ; Cetta F; Loftus CG; Connolly HM
    Am J Cardiol; 2006 Sep; 98(5):666-7. PubMed ID: 16923458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
    Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
    Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of transcatheter Fontan fenestration to treat protein losing enteropathy.
    Vyas H; Driscoll DJ; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):584-9. PubMed ID: 17323361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protein-losing enteropathy following Fontan operation for a complex heart defect].
    Galal O; Kersten J; Götze H; Stoermer J
    Monatsschr Kinderheilkd; 1984 Nov; 132(11):870-2. PubMed ID: 6513949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenestration of extracardiac fontan and reversal of protein-losing enteropathy: case report.
    Lemes V; Murphy AM; Osterman FA; Laschinger JC; Kan JS
    Pediatr Cardiol; 1998; 19(4):355-7. PubMed ID: 9636262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual treatment for protein losing enteropathy.
    Windram JD; Clift PF; Speakman J; Thorne SA
    Congenit Heart Dis; 2011; 6(3):253-6. PubMed ID: 21418528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legionella pneumonia and bacteraemia in association with protein-losing enteropathy after Fontan operation.
    Cheung YF; Leung MP; Yuen KY
    J Infect; 2001 Apr; 42(3):206-7. PubMed ID: 11545554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation.
    Bhagirath KM; Tam JW
    Ann Thorac Surg; 2007 Dec; 84(6):2110-2. PubMed ID: 18036954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.